Healthcare provider profile · identity verified

Michael James Davis, FNP-BC

Nurse Practitioner · TOPSHAM, ME · NPI 1942811161

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Furosemide	Furosemide	380	45
Levothyroxine Sodium	Levothyroxine Sodium	347	47
Eliquis	Apixaban	327	42
Atorvastatin Calcium	Atorvastatin Calcium	272	74
Gabapentin	Gabapentin	232	48
Sertraline Hcl	Sertraline Hcl	227	44
Metoprolol Tartrate	Metoprolol Tartrate	145	34
Buspirone Hcl	Buspirone Hcl	135	23
Amlodipine Besylate	Amlodipine Besylate	128	35
Metoprolol Succinate	Metoprolol Succinate	126	38
Jardiance	Empagliflozin	124	12
Tamsulosin Hcl	Tamsulosin Hcl	107	27
Losartan Potassium	Losartan Potassium	105	25
Lisinopril	Lisinopril	104	20
Duloxetine Hcl	Duloxetine Hcl	102	25
Oxycodone Hcl	Oxycodone Hcl	98	43
Trazodone Hcl	Trazodone Hcl	97	30
Myrbetriq	Mirabegron	92	suppressed
Mirtazapine	Mirtazapine	87	16
Xarelto	Rivaroxaban	86	suppressed
Omeprazole	Omeprazole	81	16
Potassium Chloride	Potassium Chloride	80	21
Metformin Hcl	Metformin Hcl	77	18
Simvastatin	Simvastatin	76	17
Tramadol Hcl	Tramadol Hcl	68	21
Pantoprazole Sodium	Pantoprazole Sodium	66	23
Allopurinol	Allopurinol	65	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	62	11
Baclofen	Baclofen	59	11
Famotidine	Famotidine	55	14
Ondansetron Hcl	Ondansetron Hcl	55	22
Lorazepam	Lorazepam	54	20
Albuterol Sulfate Hfa	Albuterol Sulfate	52	39
Torsemide	Torsemide	51	19
Oxybutynin Chloride	Oxybutynin Chloride	50	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	48	suppressed
Entresto	Sacubitril/Valsartan	47	suppressed
Fluticasone Propionate	Fluticasone Propionate	46	26
Risperidone	Risperidone	45	suppressed
Lactulose	Lactulose	43	13
Methenamine Hippurate	Methenamine Hippurate	43	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	43	14
Spironolactone	Spironolactone	43	11
Morphine Sulfate	Morphine Sulfate	42	14
Montelukast Sodium	Montelukast Sodium	38	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	36	11
Levetiracetam	Levetiracetam	36	suppressed
Bupropion Xl	Bupropion Hcl	34	suppressed
Alprazolam	Alprazolam	33	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	33	19
Doxycycline Hyclate	Doxycycline Hyclate	32	16
Ropinirole Hcl	Ropinirole Hcl	32	11
Hydrochlorothiazide	Hydrochlorothiazide	31	suppressed
Meclizine Hcl	Meclizine Hcl	31	suppressed
Tizanidine Hcl	Tizanidine Hcl	31	suppressed
Nitroglycerin	Nitroglycerin	30	25
Clopidogrel	Clopidogrel Bisulfate	29	suppressed
Cyclosporine	Cyclosporine	29	suppressed
Finasteride	Finasteride	27	suppressed
Divalproex Sodium	Divalproex Sodium	26	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	25	suppressed
Citalopram Hbr	Citalopram Hydrobromide	24	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	24	suppressed
Prednisone	Prednisone	24	12
Cephalexin	Cephalexin	23	suppressed
Ezetimibe	Ezetimibe	23	suppressed
Donepezil Hcl	Donepezil Hcl	22	suppressed
Lumigan	Bimatoprost	22	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	21	12
Atenolol	Atenolol	21	suppressed
Dilt-Xr	Diltiazem Hcl	21	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Latanoprost	Latanoprost	20	suppressed
Prazosin Hcl	Prazosin Hcl	20	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	19	12
Fentanyl	Fentanyl	19	suppressed
Lamotrigine	Lamotrigine	19	suppressed
Restasis	Cyclosporine	19	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	18	suppressed
Pregabalin	Pregabalin	18	suppressed
Armour Thyroid	Thyroid,pork	17	suppressed
Solifenacin Succinate	Solifenacin Succinate	17	suppressed
Warfarin Sodium	Warfarin Sodium	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Carvedilol	Carvedilol	16	suppressed
Neomycin-Polymyxin-Dexameth	Neomycin/Polymyxin B/Dexametha	16	suppressed
Carbamazepine	Carbamazepine	15	suppressed
Chlorthalidone	Chlorthalidone	15	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	15	12
Dorzolamide Hcl	Dorzolamide Hcl	15	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	15	suppressed
Bumetanide	Bumetanide	14	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	14	suppressed
Estradiol	Estradiol	14	suppressed
Memantine Hcl Er	Memantine Hcl	14	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	14	suppressed
Amiodarone Hcl	Amiodarone Hcl	13	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	13	suppressed
Fosfomycin Tromethamine	Fosfomycin Tromethamine	13	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	13	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	suppressed
Timolol Maleate	Timolol Maleate	13	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	13	suppressed
Azithromycin	Azithromycin	12	suppressed
Benztropine Mesylate	Benztropine Mesylate	12	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	12	suppressed
Doxepin Hcl	Doxepin Hcl	12	suppressed
Dutasteride	Dutasteride	12	suppressed
Fluconazole	Fluconazole	12	suppressed
Glycopyrrolate	Glycopyrrolate	12	suppressed
Lorazepam Intensol	Lorazepam	12	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	12	suppressed
Phenazopyridine Hcl	Phenazopyridine Hcl	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Rybelsus	Semaglutide	12	suppressed
Scopolamine	Scopolamine	12	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	11	suppressed
Atropine Sulfate	Atropine Sulfate	11	11
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Flecainide Acetate	Flecainide Acetate	11	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	11	suppressed
Fluticasone-Vilanterol	Fluticasone/Vilanterol	11	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	11	suppressed
Midodrine Hcl	Midodrine Hcl	11	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	11	suppressed
Ranolazine Er	Ranolazine	11	suppressed
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error